Clinical Trial Update: Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating low-dose radiation with SBRT plus Sintilimab and chemotherapy versus Sintilimab and chemotherapy in locally advanced or metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Sintilimab (Tyvyt) (sintilimab)

Snippet

Sponsor: Sichuan University | Conditions: Lung Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING